The nation of Zimbabwe has turned down a major US healthcare agreement worth $367m (£272m) over five years because of Washington's insistence on sensitive data.
This rejection was revealed after a government memo from December was leaked, revealing that Head of State Emmerson Mnangagwa believed the arrangement was "lopsided".
An official spokesperson later stated that the United States was requesting health data for research and commercial gain while was unwilling to guarantee the benefits from any future vaccines.
"We are forced to start the challenging and unfortunate task of winding down our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had provided more than $1.9bn for health programmes to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has appealed for continued negotiations to secure a agreement acceptable to both sides so the country's vital HIV programme can continue.
Broader Implications
Zimbabwe's decision comes after a similar situation in Kenya, where a high court suspended a related health funding agreement after legal challenges were filed about the safety of Kenyans' medical information.
Since returning to the presidency recently, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
The agency had overseen aid for the American government, but Trump claimed its spending was "inefficient" and his government was seeking government-to-government deals to boost openness and responsibility.
According to statements, Sixteen African countries have to date signed these new agreements, representing over $18.3bn of fresh investment.
Specifics of the Declined Agreement
This assistance for Zimbabwe would have gone towards "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this cooperation would have delivered significant benefits for the people of Zimbabwe, especially the 1.2 million currently receiving antiretroviral therapy through American-funded initiatives," Tremont said.
However, government spokesperson Nick Mangwana argued the proposed deal was "unfair".
"Zimbabwe was being asked to surrender its biological resources and data for a long time, with no corresponding assurance of benefiting from any medical innovations – such as new medicines or tests – that could be developed from that provided information," his statement read.
"Effectively, our nation would provide the basic resources for scientific discovery without any certainty that the end products would be accessible to our citizens if a new pandemic emerge."
Sovereignty and Global Health
Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were undermining frameworks previously established through the global organization.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme designed to manage future pandemics.
"This framework is intended to ensure that when a country provides its samples, the benefits – including medicines and cures – are distributed fairly, not commercialised exclusively by those with the resources to create them."
These objections regarding the US deal "should not be misconstrued as hostility towards the US," he added.
"We encourage continued dialogue with our American counterparts on how future co-operation could be structured in a way that respects the sovereignty and dignity of both nations."
Health Experts Response
Medical experts said it understood the official position, but suggested that negotiations must proceed given that much of the nation's Aids initiatives relied on foreign aid.
"Where specific concerns arise, such as those relating to data governance or implementation frameworks, these can frequently be addressed through detailed discussion and negotiated safeguards," it said.
This impasse underscores the ongoing tensions between accepting crucial foreign assistance and protecting local interests in an ever more interconnected world.